Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

NCT01006369 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: hydroxychloroquine

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]